SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Resverlogix Corporation Establishes Clinical & Scientific Advisory Board to Support the Clinical Development of RVX-208 and Other Bromodomain Inhibitors in Neurodegenerative Diseases